CTT Pharmaceutical Financials
| CTTH Stock | USD 0.06 0 6.19% |
CTT |
Understanding current and past CTT Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CTT Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in CTT Pharmaceutical's assets may result in an increase in income on the income statement.
CTT Pharmaceutical Stock Summary
CTT Pharmaceutical competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, and DiaMedica Therapeutics. CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US12651E1064 |
| Business Address | 429 Kent Street |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cttpharmaceuticals.com |
| Phone | 613 241 9959 |
| Currency | USD - US Dollar |
CTT Pharmaceutical Key Financial Ratios
CTT Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from CTT Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of CTT Pharmaceutical over time and compare it to other companies across industries.CTT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CTT Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CTT Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CTT Pharmaceutical competition to find correlations between indicators driving CTT Pharmaceutical's intrinsic value. More Info.CTT Pharmaceutical Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CTT Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CTT Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CTT Pharmaceutical Systematic Risk
CTT Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CTT Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on CTT Pharmaceutical correlated with the market. If Beta is less than 0 CTT Pharmaceutical generally moves in the opposite direction as compared to the market. If CTT Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CTT Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CTT Pharmaceutical is generally in the same direction as the market. If Beta > 1 CTT Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
CTT Pharmaceutical November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CTT Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CTT Pharmaceutical Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of CTT Pharmaceutical Holdings based on widely used predictive technical indicators. In general, we focus on analyzing CTT Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CTT Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 15.75 | |||
| Information Ratio | 0.0629 | |||
| Maximum Drawdown | 199.35 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 12.0 |
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |